Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Ambazone→

Ambazone Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
539-21-9
Molecular formula
C8H11N7S
Molecular weight
237.29 g/mol
Drug class
Topical antisepticaromatic thiosemicarbazone derivative
Mechanism of action
Exerts local antimicrobial activity against selected bacteria, particularly Gram-positive organisms; the exact molecular target and clinical mechanism are not fully established.
Indications / reported uses
  • Local symptomatic treatment of sore throat and oropharyngeal infections with authorised lozenge preparations in countries where ambazone remains marketed; not a substitute for systemic antibiotic treatment when indicated

Sources: NLM MeSH — Ambazone · PubMed — Ambazone antibacterial lozenge · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Ambazone Environmental Risk Assessment (ERA) (the Ambazone ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.